|
Market Closed -
Bombay S.E.
03:32:25 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 76.90 INR | -3.20% |
|
-2.34% | -11.46% |
Company Valuation: Astal Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 36.52 | 34.77 | 64.34 | 118.1 | 401.9 | 747.2 |
| Change | - | -4.79% | 85.03% | 83.54% | 240.29% | 85.93% |
| Enterprise Value (EV) 1 | 36.38 | 34.46 | 64.16 | 117.2 | 344.2 | 862.6 |
| Change | - | -5.27% | 86.18% | 82.75% | 193.57% | 150.59% |
| P/E | -130x | 577x | -376x | 722x | 26.3x | 9.45x |
| PBR | 0.71x | 0.67x | 1.25x | 2.27x | 1.72x | 2.08x |
| PEG | - | -5x | 1x | -4x | 0x | 0x |
| Capitalization / Revenue | 18.1x | 17.2x | 30.5x | 3.27x | 1.7x | 1.17x |
| EV / Revenue | 18x | 17.1x | 30.4x | 3.25x | 1.45x | 1.36x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0708 | 0.0152 | -0.0431 | 0.041 | 1.554 | 8.043 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 2.019 | 2.019 | 2.108 | 36.07 | 236.6 | 636.6 |
| EBITDA | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - |
| Net income 1 | -0.2815 | 0.0602 | -0.1711 | 0.164 | 7.847 | 89.25 |
| Net Debt 1 | -0.1448 | -0.3129 | -0.1828 | -0.844 | -57.64 | 115.4 |
| Reference price 2 | 9.19 | 8.75 | 16.19 | 29.60 | 40.88 | 76.01 |
| Nbr of stocks (in thousands) | 3,974 | 3,974 | 3,974 | 3,990 | 9,830 | 9,830 |
| Announcement Date | 10/09/20 | 01/09/21 | 08/09/22 | 25/08/23 | 12/07/24 | 18/08/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 3.68Cr | ||
| 33.01x | 11.99x | 24.31x | 0.6% | 1,03400Cr | ||
| 30.97x | - | - | 1.93% | 67TCr | ||
| 33.21x | 7.7x | 16x | 2.64% | 46TCr | ||
| 19.86x | 4.73x | 11.71x | 2.8% | 35TCr | ||
| 23.09x | 5.93x | 14.7x | 2.69% | 31TCr | ||
| 21.15x | 4.34x | 12.39x | 2.03% | 26TCr | ||
| 28.09x | 7.23x | 12.82x | 2.27% | 24TCr | ||
| 13.44x | 4.86x | 10.14x | 3.75% | 21TCr | ||
| -46.21x | 6.66x | 25.99x | 2.18% | 19TCr | ||
| Average | 17.40x | 6.68x | 16.01x | 2.32% | 37.17TCr | |
| Weighted average by Cap. | 24.37x | 8.05x | 17.85x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MACINTR Stock
- Valuation Astal Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















